Literature DB >> 21108016

An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue.

Segundo Jaime González1, Lorena González, Joyce Wong, Peter Brader, Maureen Zakowski, Mithat Gönen, Farhad Daghighian, Yuman Fong, Vivian E Strong.   

Abstract

INTRODUCTION: The intraoperative localization of suspicious lesions detected by positron emission tomography (PET) scan remains a challenge. To solve this, two novel probes have been created to accurately detect the (18)F-FDG radiotracer intraoperatively.
METHODS: Nude rats were inoculated with mesothelioma. When PET scans detected 10-mm tumors, animals were dissected and the PET probes analyzed the intraoperative radiotracer uptake of these lesions as tumor to background ratio (TBR).
RESULTS: The 17 suspicious lesions seen on PET scan were localized intraoperatively (by their high TBR) using the PET probes and found malignant on pathology. Interestingly, smaller tumors not visualized on PET scan were detected intraoperatively by their high TBR and found malignant on pathology. Furthermore, using a TBR threshold as low as 2.0, both gamma (sensitivity, 100%; specificity, 80%; positive predictive value (PPV), 96%; and negative predictive value (NPV), 100%) and beta (sensitivity, 100%; specificity, 60%; PPV, 93%; and NPV, 100%) probes reliably detected suspicious lesions on PET scan imaging. They also showed an excellent area under the curve of 0.9 and 0.97 (95% CI of 0.81-0.99 and 0.93-1.0) for gamma and beta probes, respectively, in the receiver operating characteristic analysis for detecting malignancy.
CONCLUSION: This novel tool could be used synergistically with a PET scan imaging to maximize tissue selection intraoperatively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108016      PMCID: PMC3275348          DOI: 10.1007/s11605-010-1394-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

Review 1.  Molecular imaging of cancer with positron emission tomography.

Authors:  Sanjiv Sam Gambhir
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

2.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

3.  Cellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium?

Authors:  Andreas K Buck; Sven N Reske
Journal:  J Nucl Med       Date:  2004-03       Impact factor: 10.057

4.  Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

Authors:  W Wang; S M Larson; M Fazzari; S K Tickoo; K Kolbert; G Sgouros; H Yeung; H Macapinlac; J Rosai; R J Robbins
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

5.  [Positron emission tomography in clinical oncology].

Authors:  H Foehrenbach; J-L Albérini; P Maszelin; G Bonardel; F Tenenbaum; O de Dreuille; B Richard; J-F Gaillard; J-Y Devaux
Journal:  Presse Med       Date:  2003-02-15       Impact factor: 1.228

6.  The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.

Authors:  Seza A Gulec; Mark B Faries; Chris C Lee; Daniel Kirgan; C Glass; Donald L Morton; Richard Essner
Journal:  Clin Nucl Med       Date:  2003-12       Impact factor: 7.794

7.  What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.

Authors:  Tatsuya Higashi; Tsuneo Saga; Takayoshi Ishimori; Marcelo Mamede; Koichi Ishizu; Toru Fujita; Takahiro Mukai; Seiji Sato; Hironori Kato; Yoshio Yamaoka; Keiichi Matsumoto; Michio Senda; Junji Konishi
Journal:  Ann Nucl Med       Date:  2004-04       Impact factor: 2.668

Review 8.  Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.

Authors:  Bastiaan Wiering; Theo J M Ruers; Wim J G Oyen
Journal:  Expert Rev Anticancer Ther       Date:  2004-08       Impact factor: 4.512

Review 9.  FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.

Authors:  Wulf Siggelkow; Werner Rath; Udalrich Buell; Michael Zimny
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-14       Impact factor: 9.236

10.  Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer.

Authors:  J W B de Groot; Th P Links; P L Jager; T Kahraman; J Th M Plukker
Journal:  Ann Surg Oncol       Date:  2004-08       Impact factor: 5.344

View more
  1 in total

1.  A novel radioguided surgery technique exploiting β(-) decays.

Authors:  E Solfaroli Camillocci; G Baroni; F Bellini; V Bocci; F Collamati; M Cremonesi; E De Lucia; P Ferroli; S Fiore; C M Grana; M Marafini; I Mattei; S Morganti; G Paganelli; V Patera; L Piersanti; L Recchia; A Russomando; M Schiariti; A Sarti; A Sciubba; C Voena; R Faccini
Journal:  Sci Rep       Date:  2014-03-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.